RxDoctor Payments Data

Katharine Cronk, MD

Neurological Surgery · Nashua, NHNPI 1669652715

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Spineart SA at 48.5% of the total. Reporting peaked in 2024 at $1,144 and has fallen 61.6% since, to $440 in 2025. That places this record below the midpoint for neurological surgery clinicians in NH, where the typical reported total is $2,435.

$2,262in general payments, 2019–2025

Across 32 payments — averaging $70.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart SA$1K
  • Boston Scientific$374
  • Relievant Medsystems, Inc.$196
  • MML US, Inc.$177
  • Medtronic$120
  • Stryker$83
  • plus $214 from 8 others

What the payments were for

  • Travel & lodging$1,09749%
  • Food & beverage$1,16551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,262 in reported general payments places this provider in the 45th percentile of 32 neurological surgery providers in New Hampshire.

See all neurological surgery providers in New Hampshire

Medicare billing

Part B allowed, 2024
$123,362
Medicare patients
212
Services billed
471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$186
Cyclobenzaprine Hcl11$97

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Nashua

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →